Modern Technology Offers Revolutionary Opportunities for Breast Imaging Market

According to a study by Market Research Future, the global breast imaging market will grow to 6.8 billion by 2030 at a compound annual growth rate of 8.3%. (MRFR).Breast imaging is a type of medical imaging used to detect abnormalities in the consistency and size of breast tissues as part of the diagnosis and treatment of various diseases. Computed tomography (CT), x-rays (radiography), mammography (mammography), and magnetic resonance imaging (MRI) are all examples of state-of-the-art medical technology that help physicians diagnose and treat diseases of the breast. Innovations in imaging technology are the primary force propelling the global breast imaging market.

Global Breast Imaging Market Overview

The Breast Imaging market is expected to reach USD 6.8 billion by 2030 at 8.3% CAGR during the forecast period 2022-2030.

Breast imaging is the current gold standard for detecting breast cancer, the most frequent malignancy in females. The World Health Organization (WHO) forecasts that 2 million new instances of breast cancer will be diagnosed in 2018. (WHO). An upsurge in the global demand for breast imaging services is being fueled by the alarmingly rising rates of breast cancer.Moreover, growing collaboration between industry and government initiatives to promote diagnosis of breast cancer early is likely to fuel the growth of the market. Increasing awareness among people and availability of sophisticated technologies are There are only a select few other trends that are likely to propel the global breast imaging market forward.

The market for highly sophisticated medical diagnostic tools is predicted to increase rapidly to meet rising consumer demand. However, the high cost associated with breast imaging procedures coupled with the lack of trained professionals remain major market challenges.

Market Segmentation

The global breast imaging market has been segmented based on technology, end-user, and region.Based on technology, the breast imaging market is segmented into computed tomography (CT), mammography, digital breast tomosynthesis, ultrasonography, special imaging, and magnetic resonance imaging (MRI).By end-user, the breast imaging market is segmented into hospitals, research centers, and diagnostic centers.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Breast Imaging Market Research Report

Regional Analysis

Market researchers have divided the worldwide demand for breast imaging machines into North America, South America, Europe, Asia Pacific, and the Middle East and Africa.

For breast imaging, North America is expected to be the largest market worldwide due to the region’s highly developed healthcare sector and wide availability of technologically advanced imaging equipment. In addition, the regional market is expected to be propelled by the presence of well-established competitors and rising spending in R&D activities.The second largest market for breast imaging is in Europe, specifically the United Kingdom, France, and Italy, where there is a greater than average awareness and incidence of breast cancer.

Due to increasing healthcare spending and greater public knowledge about breast cancer, the Asia-Pacific area is predicted to expand at a stable rate, with India and China as the region's primary income generators.

Market Forecast

Over the forecast period of 2019–2025, the market for breast imaging is projected to expand at a robust 6.9% CAGR. The rising need for early diagnosis and treatment of breast cancer is expected to attract a slew of investments for new product releases and technical innovation, despite the industry being plagued by issues such as price and a lack of competent specialists.

Companies Profiled

Some of the major companies in the global breast imaging market include GE Healthcare (U.S.), CMR Naviscan (U.S.), Amrad Corporation (Australia), Siemens AG (Germany), Fujifilm Holding Corporation (Japan), Hologic Inc. (U.S.), Philips Healthcare (Netherlands), Canon Medical Systems Corporation (Japan), United Imaging Healthcare (China), and RimElements, Inc. (U.S.).